Partners

During the second quarter of 2024, Virtus Investment Partners (ticker: NYSE:) experienced both challenges and growth. President and CEO George Aylward reported net outflows in line with industry trends but also highlighted areas of growth, such as Retail Separate Accounts, ETFs, and Global Funds. The company’s earnings and operating margins…

Ferrellgas Partners (FGP) reported mixed results in their Third Quarter Fiscal ’24 Earnings Conference Call, with CEO Tamria Zertuche highlighting the company’s strategic initiatives and the resilience of its employees in the face of challenging weather conditions. While revenues dipped, the company saw a gross profit increase and a significant…

By David Shepardson WASHINGTON (Reuters) – The U.S.-led Indo-Pacific Economic Framework is holding a ministerial meeting this week in Singapore, including major firms joining a “Clean Economy” investor forum to boost infrastructure and climate investments across the region. It marks the first in-person IPEF ministerial session since the substantial conclusion…

Fulcrum Therapeutics (ticker: NASDAQ:) has entered into a significant collaboration with Sanofi (NASDAQ:) for the development and commercialization of losmapimod, aimed at treating facioscapulohumeral muscular dystrophy (FSHD) outside the United States. This partnership includes an $80 million upfront payment to Fulcrum, with the possibility of an additional $975 million based…

Kimbell Royalty Partners, LP (NYSE:) Controller Blayne Rhynsburger sold a total of 6,487 common units representing limited partner interests on March 19, 2024, for a total transaction value of approximately $101,197. The sale was executed at a price of $15.60 per share, according to a recent SEC filing. The transaction…